For EXO-NET exosome isolation and nucleic acid purification solutions
INOVIQ Limited (ASX:IIQ) (INOVIQ), an innovative developer of exosome solutions and precision diagnostics, and Promega Corporation (Promega), a global leader in innovative technologies, tools and technical support to the life sciences industry, today announced a joint marketing agreement to co-market INOVIQ’s EXO-NET® exosome capture technology and Promega Nucleic Acid purification systems worldwide.
A global solution to deliver exosome to customers for manual and high-throughput exosome isolation and nucleic acid extraction.
This agreement expected to deliver world-class exosome tools and technologies to researchers, pharma and clinical laboratories globally to enable their exosome isolation, biomarker discovery and diagnostics needs.